Cargando…
Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer
Breast cancer is a frequent and treatable disease. However, when recurrent, breast cancer often becomes refractory to therapy and progresses into metastatic forms that are typically incurable. Thus, understanding and targeting the critical pathways underlying breast cancer recurrence is urgently nee...
Autores principales: | Segatto, Ilenia, Massarut, Samuele, Boyle, Robert, Baldassarre, Gustavo, Walker, David, Belletti, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931847/ https://www.ncbi.nlm.nih.gov/pubmed/27155197 http://dx.doi.org/10.18632/aging.100954 |
Ejemplares similares
-
p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation
por: Segatto, Ilenia, et al.
Publicado: (2014) -
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
por: Segatto, Ilenia, et al.
Publicado: (2014) -
STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context
por: Segatto, Ilenia, et al.
Publicado: (2018) -
Time-tuning cancer therapy
por: Baldassarre, Gustavo, et al.
Publicado: (2015) -
p27(kip1) expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms
por: Pellizzari, Ilenia, et al.
Publicado: (2016)